Pembrolizumab (Renal cell carcinoma): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 9 September 2022 Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 1.3MB) Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 1.1 MB)